as on November 7, 2025 at 2:29 am IST
Day's Low
Day's High
13.72%
Downside
3.25%
Upside
52 Week's Low
52 Week's High
46.82%
Downside
561.95%
Upside
Check Aligos Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$50.1M
EPS (TTM)
-7.88
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-13.35
Industry PE ratio
-2.8140502793296087
PEG Ratio
0EBITDA
-77.6M
Revenue (TTM)
3.2M
Profit Margin
0.00%
Return On Equity TTM
-87.74%
Track how Aligos Therapeutics Inc P/E has moved over time to understand its valuation trends.
Aligos Therapeutics Inc in the last 5 years
Lowest (-116.34x)
September 30, 2021
Today (-13.35x)
November 6, 2025
Industry (-2.81x)
November 6, 2025
Highest (-0.30x)
June 30, 2025
Today’s Price to Earnings Ratio: -13.35x
Compare market cap, revenue, PE, and other key metrics of Aligos Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $50.1M | -98.06% | -13.35 | 0.00% | |
| BUY | $39.9B | 473.78% | -16.34 | -264.83% | |
| BUY | $55.9B | 232.41% | 1411.57 | 1.36% | |
| BUY | $108.1B | 89.3% | 29.63 | 31.86% | |
| BUY | $67.5B | 11.45% | 15.38 | 32.13% |
The Aligos Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Aligos Therapeutics Inc investment value today
Current value as on today
₹80,651
Returns
Returns from Aligos Therapeutics Inc Stock
Dollar Returns*
₹5,036 (+5.04%)
Based on 8 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Aligos Therapeutics Inc. Average target price of $80.25
Get share price movements and forecasts by analysts on Aligos Therapeutics Inc.
What analysts predicted
91.19%UPSIDE
Target Price
$80.25
Current Price
$7.07
Analyzed by
8 Analysts
Target
$80.25
Aligos Therapeutics Inc target price $80.25, a slight upside of 91.19% compared to current price of $7.07. According to 8 analysts rating.
Search interest for Aligos Therapeutics Inc Stock has increased by 91% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:91% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 311.0K → 965.0K (in $), with an average increase of 67.8% per quarter
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 926.8% return, outperforming this stock by 997.2%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 156.5% return, outperforming this stock by 178.1%
Price Dip
![]()
In the last 7 days, ALGS stock has moved down by -10.6%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 43.08M → -15.86M (in $), with an average decrease of 136.8% per quarter
| Organisation | Aligos Therapeutics Inc |
| Headquarters | One Corporate Drive, South San Francisco, CA, United States, 94080 |
| Industry | Health Technology |
| CEO | Dr. Lawrence M. Blatt MBA, Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Lesley Ann Calhoun CPA | Executive VP, CFO & COO |
Ms. Laura Kavanaugh | VP & Head of Legal |
Dr. Sushmita M. Chanda DABT, Ph.D. | Executive Vice President & Chief Development Officer |
Dr. David B. Smith Ph.D. | Executive VP & Head of Chemical Operations |
Dr. Hardean E. Achneck M.D. | Executive VP & Chief Medical Officer |
Dr. Kieron Wesson Ph.D. | Vice President & Head of Chemistry Manufacturing Controls |
Dr. Lawrence M. Blatt MBA, Ph.D. | CEO, President & Chairman of the Board |
Dr. Julian A. Symons DPHIL | Executive VP & Chief Scientific Officer |
Ms. Kristina Engeseth M.B.A. | Senior VP and Head of People & Culture |
Dr. Tse-I Lin Ph.D. | Senior VP of Early Compound Development & Belgian Site Head |
Aligos Therapeutics Inc share price today is $7.07 as on at the close of the market. Aligos Therapeutics Inc share today touched a day high of $7.3 and a low of $6.1.
Aligos Therapeutics Inc share touched a 52 week high of $46.8 on and a 52 week low of $3.76 on . Aligos Therapeutics Inc stock price today i.e. is closed at $7.07,which is 84.89% down from its 52 week high and 88.03% up from its 52 week low.
Aligos Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Aligos Therapeutics Inc (ALGS) shares with as little as ₹88.566 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹885.66 in Aligos Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aligos Therapeutics Inc share’s latest price of $7.07 as on November 7, 2025 at 2:29 am IST, you will get 1.4144 shares of Aligos Therapeutics Inc. Learn more about
fractional shares .
Aligos Therapeutics Inc stock has given -98.06% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?